Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Pipeline
    • Corporate Social Responsibility
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT®|BONE VOID FILLER
    • CERAMENT®
    • CERAMENT BEAD TRAY
    • Purchasing Products
    • CERAMENT®|BONE VOID FILLER transition facts
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • FORTIFY Clinical Trial
    • REVISION ARTHROPLASTY: WHY USE CERAMENT
    • FOOT AND ANKLE: WHY USE CERAMENT
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Calendar
    • Q&A
    • Corporate Governance
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Research
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Shareholders
  • Analyst Coverage
  • Calendar
  • Definitions
  • Q&A
  • Corporate Governance

Financial Reports

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

Financial Reports 2020
Financial Reports 2019
Financial Reports 2018
Financial Reports 2017
Other Reports

©BONESUPPORT AB 2021. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy